Chemed (CHE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Chemed (CHE) emitió su última guía sobre julio 28, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $25 - $25.75, en comparación con una estimación de consenso de EPS de $24.01.
En comparación con la previsión anterior, Chemed elevado redujo su previsión de BPA desde un rango anterior de $24 - $24.75.
Chemed ha emitido 14 actualizaciones de orientación entre el octubre 31, 2022 y el julio 28, 2026. During this period, the company raised its outlook 6 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $5.50 | $5.21 | $6.85 | $5.19 |
| Actual | $6.06 | $5.65 | $6.42 | $5.27 |
| Surprise | +10.2% | +8.45% | -6.28% | +1.54% |
| Revenue | ||||
| Estimate | $664.2M | $648.0M | $657.9M | $626.8M |
| Actual | $673.3M | $657.5M | $639.3M | $624.9M |
| Surprise | +1.36% | +1.46% | -2.82% | -0.30% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $6.37 | $7.20 | $5.81 | $5.90 |
| Revenue | ||||
| Consensus | $683.6M | $705.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $6.06 | $5.50 | 10.2 % |
| Q1 | Apr 23, 2026 | $5.65 | $5.21 | 8.45 % |
| Q4 | Feb 25, 2026 | $6.42 | $6.85 | -6.28 % |
| Q3 | Oct 28, 2025 | $5.27 | $5.19 | 1.54 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $673.25M | $664.21M | 1.36 % |
| Q1 | Apr 23, 2026 | $657.51M | $648.04M | 1.46 % |
| Q4 | Feb 25, 2026 | $639.34M | $657.88M | -2.82 % |
| Q3 | Oct 28, 2025 | $624.90M | $626.79M | -0.30 % |